BCIQ Profiles

Company Profile Report
0726 China stocks
BioCentury & Getty Images


China’s market jitters clip biopharma shares

Bellwethers tumble, biotech ETFs down 7% after Beijing’s latest regulatory move

Jul 27, 2021 | 2:20 AM GMT

Concerns that biopharma could become the next industry to be scrutinized by Beijing sent shares falling in Hong Kong and New York Monday after a government directive related to the education sector has decreed that academic tutoring companies can no longer be publicly traded. Two investors who spoke to BioCentury and remain upbeat on China biotech explain what’s behind the sector’s latest roller-coaster ride.


Read the full 927 word article

How to gain access

Continue reading with a
two-week free trial.